カテゴリ： MarketLine, 企業調査, 日本

Chugai Pharmaceutical Co., Ltd.：企業の戦略・SWOT・財務情報

◆英語タイトル：Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C6903
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：53
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：日本
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Chugai Pharmaceutical Co., Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

Chugai Pharmaceutical Co., Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Chugai Pharmaceutical (Chugai or ‘the company’), the Japanese subsidiary of the Roche Group, is engaged in biopharmaceutical research and development. It produces antibody drugs primarily focusing on oncology, renal diseases and bone and joint diseases. The company operates in Japan, Switzerland and other regions of the world. It is headquartered in Tokyo, Japan.

Scope

- Detailed information on Chugai Pharmaceutical Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Chugai Pharmaceutical Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Chugai Pharmaceutical Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on Chugai Pharmaceutical Co., Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Chugai Pharmaceutical Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Chugai Pharmaceutical Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Chugai Pharmaceutical Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Chugai Pharmaceutical Co., Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Chugai Pharmaceutical Co., Ltd.: Company Overview 9
Chugai Pharmaceutical Co., Ltd.: Overview and Key Facts 9
Chugai Pharmaceutical Co., Ltd.: Overview 9
Chugai Pharmaceutical Co., Ltd.: Key Facts 9
Chugai Pharmaceutical Co., Ltd.: Key Employees 11
Chugai Pharmaceutical Co., Ltd.: Key Employee Biographies 14
Chugai Pharmaceutical Co., Ltd.: Major Products and Services 18
Chugai Pharmaceutical Co., Ltd.: Company History 19
Chugai Pharmaceutical Co., Ltd.: Management Statement 26
Chugai Pharmaceutical Co., Ltd.: Locations and Subsidiaries 29
Chugai Pharmaceutical Co., Ltd.: Key Competitors 30
Chugai Pharmaceutical Co., Ltd.: Company Analysis 31
Chugai Pharmaceutical Co., Ltd.: Business Description 31
Chugai Pharmaceutical Co., Ltd.: SWOT Analysis 32
Chugai Pharmaceutical Co., Ltd.: SWOT Overview 32
Chugai Pharmaceutical Co., Ltd.: Strengths 32
Chugai Pharmaceutical Co., Ltd.: Weaknesses 33
Chugai Pharmaceutical Co., Ltd.: Opportunities 34
Chugai Pharmaceutical Co., Ltd.: Threats 35
Chugai Pharmaceutical Co., Ltd.: Corporate Financial Deals Activity 37
Chugai Pharmaceutical Co., Ltd.: Financial Deals Overview 37
Chugai Pharmaceutical Co., Ltd.: Targets and Partners 39
Chugai Pharmaceutical Co., Ltd.: Top Deals 2014 – 2018YTD* 40
Chugai Pharmaceutical Co., Ltd.: Partnership 41
Chugai Pharmaceutical Co., Ltd.: Divestments 42
Chugai Pharmaceutical Co., Ltd.: Recent Developments 43
Chugai Pharmaceutical Co., Ltd.: News and Events Summary 43
Chugai Pharmaceutical Co., Ltd.: Business Expansion 46
Chugai Pharmaceutical Co., Ltd.: Contracts 46
Chugai Pharmaceutical Co., Ltd.: Corporate Governance 47
Chugai Pharmaceutical Co., Ltd.: Corporate Social Responsibility 48
Chugai Pharmaceutical Co., Ltd.: Grants 48
Chugai Pharmaceutical Co., Ltd.: Regulatory and Legal Events 49
Chugai Pharmaceutical Co., Ltd.: Research & Development 50
Chugai Pharmaceutical Co., Ltd.: Strategy and Operations 50
Appendix 51
Contact Us 51
Methodology 51
About MarketLine 52

List of Tables
Table 1: Chugai Pharmaceutical Co., Ltd.: Key Facts
Table 2: Chugai Pharmaceutical Co., Ltd.: Key Employees
Table 3: Chugai Pharmaceutical Co., Ltd.: Company History
Table 4: Chugai Pharmaceutical Co., Ltd.: Locations and Subsidiaries
Table 5: Chugai Pharmaceutical Co., Ltd.: Key Competitors
Table 6: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Chugai Pharmaceutical Co., Ltd.: Targets and Partners
Table 9: Chugai Pharmaceutical Co., Ltd.: Top Deals 2014 - 2018YTD*
Table 10: Chugai Pharmaceutical Co., Ltd.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 11: Chugai Pharmaceutical Co., Ltd.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 12: Chugai Pharmaceutical Co., Ltd.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 13: Chugai Pharmaceutical Co., Ltd.: News and Events Summary
Table 14: Chugai Pharmaceutical Co., Ltd.: Business Expansion
Table 15: Chugai Pharmaceutical Co., Ltd.: Contracts
Table 16: Chugai Pharmaceutical Co., Ltd.: Corporate Governance
Table 17: Chugai Pharmaceutical Co., Ltd.: Corporate Social Responsibility
Table 18: Chugai Pharmaceutical Co., Ltd.: Grants
Table 19: Chugai Pharmaceutical Co., Ltd.: Regulatory and Legal Events
Table 20: Chugai Pharmaceutical Co., Ltd.: Research & Development
Table 21: Chugai Pharmaceutical Co., Ltd.: Strategy and Operations

List of Figures
Figure 1: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Chugai Pharmaceutical Co., Ltd.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 4: Chugai Pharmaceutical Co., Ltd.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 5: Chugai Pharmaceutical Co., Ltd.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Chugai Pharmaceutical Co., Ltd.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • PICC Property and Casualty Company Limited：戦略・SWOT・企業財務分析
    PICC Property and Casualty Company Limited - Strategy, SWOT and Corporate Finance Report Summary PICC Property and Casualty Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Guangdong Zhongsheng Pharmaceutical Co Ltd (002317)：製薬・医療：M&Aディール及び事業提携情報
    Summary Guangdong Zhongsheng Pharmaceutical Co Ltd (Guangdong Zhongsheng Pharma) is a pharmaceutical company that develops, manufactures and supplies Chinese patent medicines, medicinal herbs and chemical medicines. The company offers its products in the form of tablets, capsules, pills, injections, …
  • Massachusetts Mutual Life Insurance Company：企業のM&A・事業提携・投資動向
    Massachusetts Mutual Life Insurance Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Massachusetts Mutual Life Insurance Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • pSivida Corp (PSDV)-医療機器分野：企業M&A・提携分析
    Summary pSivida Corp (pSivida) is a specialty pharmaceutical company that offers development of miniaturized, sustained-release drug delivery products and technologies. The company’s products include iluvien, retisert and durasert. Its durasert is an injectable, miniaturized, sustained-release drug …
  • Aiful Corporation：企業の戦略・SWOT・財務情報
    Aiful Corporation - Strategy, SWOT and Corporate Finance Report Summary Aiful Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ingram Micro Inc.：企業の戦略的SWOT分析
    Ingram Micro Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Alberici Corp：企業の戦略的SWOT分析
    Alberici Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Gujarat Power Corporation Ltd：電力：M&Aディール及び事業提携情報
    Summary Gujarat Power Corporation Ltd (GPCL) is a power corporation that produces and supplies renewable energy for the state of Gujarat. The corporation is also named as Nodal Agency by the Government of Gujarat for development of Solar Park. It generates solar energy from solar energy generation p …
  • Takeda Pharmaceutical Co Ltd (4502)：製薬・医療：M&Aディール及び事業提携情報
    Summary Takeda Pharmaceutical Company Ltd (Takeda) is a research-based global pharmaceutical company which focuses on the research and development, manufacture, marketing, commercialization and import and export of pharmaceutical drugs and consumer health care products. The company manufactures and …
  • International Game Technology Plc (IGT)：企業の財務・戦略的SWOT分析
    International Game Technology Plc (IGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Silicon Valley Bank：企業のM&A・事業提携・投資動向
    Silicon Valley Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Silicon Valley Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Lowe’s Companies, Inc.：企業の戦略・SWOT・財務情報
    Lowe's Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Lowe's Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Investment Technology Group, Inc.：企業の戦略・SWOT・財務情報
    Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Info Edge (India) Limited：企業のM&A・事業提携・投資動向
    Info Edge (India) Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Info Edge (India) Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Kane Biotech Inc (KNE)：企業の財務・戦略的SWOT分析
    Summary Kane Biotech Inc (Kane Biotech) is a developer of pharmaceutical products that prevent and remove microbial biofilms. The company uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. It develop …
  • Maruzen Petrochemical Co Ltd：企業の戦略的SWOT分析
    Maruzen Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • HDI-Global SE：企業の戦略・SWOT・財務分析
    HDI-Global SE - Strategy, SWOT and Corporate Finance Report Summary HDI-Global SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Aeolus Pharmaceuticals Inc (AOLS)-製薬・医療分野：企業M&A・提携分析
    Summary Aeolus Pharmaceuticals Inc (Aeolus) is a biopharmaceutical company that is developing a platform of new compounds for use in cancer, infectious diseases, central nervous system (CNS) diseases, fibrosis and biodefense. The company’s lead product, AEOL 10150 is a broad catalytic antioxidant pa …
  • Takara Bio Inc (4974)：企業の財務・戦略的SWOT分析
    Summary Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments for life sciences research. The company sells gene amplification system and offers scientific instruments. It of …
  • Alon USA Energy, Inc.：企業の戦略・SWOT・財務情報
    Alon USA Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alon USA Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆